8th November 2024
An innovative cancer-killing virus shows promise for tackling glioblastoma, an aggressive type of brain tumour, according to new results from a phase I clinical trial co-led by researchers at Barts Cancer Institute.
Read more23rd October 2024
New research reveals that the most common type of oesophageal cancer, oesophageal squamous cell carcinoma (ESCC), is composed of four distinct subtypes—each of which may benefit from different treatment approaches.
Read more10th October 2024
We recently welcomed a group of 16 cancer patient advocates into our labs for the 11th edition of our VOICE science for advocates course, co-run with the charity Independent Cancer Patients’ Voice.
Read more29th August 2024
Meet Dr Joash Joy, a postdoctoral researcher working on engineering artificial tumours to explore how cancer therapies can be made more effective.
Read more28th June 2024
Why does cancer disproportionately affect LGBTQIA+ people? We spoke to Dr Alison Berner.
Read more2nd May 2024
Professor Powles has been recognised for his transformative clinical work delivering a life-extending treatment for severe bladder cancer.
Read more